Skip to content

Skin Conditioning

TRANEXAMOYL DIPEPTIDE-33

Updated
85

Safety score · 0–100

Good

Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.

About

A dipeptide conjugate of tranexamic acid — designed to nudge melanin pathways for a more even tone. Topically benign at cosmetic levels; the prescription-drug status of tranexamic acid applies to systemic dosing only.

Function

HUMECTANTSKIN CONDITIONING - MISCELLANEOUS

Skin benefits

  • Targeted skin-tone evening
  • Tranexamic-acid-derived brightening
  • Combines with peptide signalling
  • Generally well tolerated

Known concerns

  • Tranexamic acid is a prescription drug at systemic doses (not relevant topically)
  • Limited independent cosmetic clinical data
  • Rare peptide allergy

References

EU

EU CosIng database

European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.

Related skin conditionings

Check your shelf

Find TRANEXAMOYL DIPEPTIDE-33 in your products.

Scan any cosmetic product with LuxSense to see if it contains TRANEXAMOYL DIPEPTIDE-33 and get a full ingredient breakdown with safety scores.

This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.